Seroprevalence of antibodies to Legionella pneumophila in hemodialysis patients

ONGUT, GÖZDE; YAVUZ, A; OGUNC, MERAL; TUNCER, M; OZTURK, F; MUTLU, DERYA; DONMEZ, LEVENT; COLAK, DİLEK; ERSOY, FETTAH; YAKUPOGLU, G; Gultekin, MERAL

doi:10.1016/j.transproceed.2003.11.061

Seroprevalence of antibodies to Legionella pneumophila in hemodialysis patients

ONGUT G., YAVUZ A., OGUNC D., TUNCER M., OZTURK F., MUTLU D., ...More

TRANSPLANTATION PROCEEDINGS, vol.36, no.1, pp.44-46, 2004 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 36 Issue: 1
Publication Date: 2004
Doi Number: 10.1016/j.transproceed.2003.11.061
Journal Name: TRANSPLANTATION PROCEEDINGS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.44-46
Akdeniz University Affiliated: Yes

Abstract

Patients with chronic renal failure are at increased risk for infections because of impaired cellular immunity. This study was designed to determine the prevalence of antibodies to Legionella pneumophila serogroups 1 to 6 and to evaluate the possible risk factors for Legionnaires' disease in hemodialysis patients. Serum samples to be screened for antibodies against L pneumophila and risk factor data were collected from 252 hemodialysis patients. The overall prevalence of L pneumophila antibodies in hemodialysis patients was found to be 5.16% There was no statistically significant difference between L pneumophila seropositivity and potential risk factors. Further studies are needed to determine possible risk factors for Legionnaires' disease in hemodialysis patients.